Global Acute Cholecystitis Market Report 2022: Health Insurance & Government Initiatives Boosting Sector Growth - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
November 10, 2022 Newswires
Share
Share
Post
Email

Global Acute Cholecystitis Market Report 2022: Health Insurance & Government Initiatives Boosting Sector Growth

PR Newswire

DUBLIN, Nov. 10, 2022 /PRNewswire/ -- The "Global Acute Cholecystitis Market, By Type, By Cause (Gall Bladder Stones, Tumor, Bile Duct Blockage, Microbial Infection, Others) By Diagnostic Procedure, By Treatment, By End User, By Region, Competition Forecast and Opportunities, 2027" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo

Global acute cholecystitis market is projected to accomplish an extraordinary growth in the forecast period, 2023-2027 with an impressive CAGR. The market growth can be attributed to the rising instances of gall bladder stone issues. The population is now more concerned and aware of the condition and demanding efficient and effective treatment for the same thereby aiding to the growth of the global acute cholecystitis market in the upcoming five years.

Moreover, rapidly increasing research and advancement in the pharmaceutical department that has effective drugs in the pipeline of market launch is further enunciating the growth factors of the global acute cholecystitis market in the next five years. Increasing geriatric population and their tendency of weaker health and poor health conditions are further aiding the growth of the market in the near future.

Health insurance, governmental schemes have made it more feasible for the patients to afford the treatments ad thus supporting the growth of the market. The market may experience a mild restraint due to health conscious consumers that have now changed food habits and are rejuvenating their bodies with healthier food.

Report Scope:

In this report, global Acute Cholecystitis market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Acute Cholecystitis Market, By Type:

  • Calculous Acute Cholecystitis
  • Acalculous Acute Cholecystitis

Global Acute Cholecystitis Market, By Cause:

  • Gall Bladder Stones
  • Tumor
  • Bile Duct Blockage
  • Microbial Infection
  • Others

Global Acute Cholecystitis Market, By Diagnostic Procedure:

  • Ultrasonography
  • Cholescintigraphy
  • CT Scan
  • ERCP (Endoscopic Retrograde Cholangiopancreatography)
  • Others

Global Acute Cholecystitis Market, By Treatment:

  • Surgical
  • Non-Surgical

Global Acute Cholecystitis Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Global Acute Cholecystitis Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Sweden
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Bangladesh
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Chile

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Acute Cholecystitis Treatment Market

4. Executive Summary

5. Voice of Customer

6. Global Acute Cholecystitis Treatment Market Outlook

7. North America Acute Cholecystitis Treatment Market Outlook

8. Europe Acute Cholecystitis Treatment Market Outlook

9. Asia-Pacific Acute Cholecystitis Treatment Market Outlook

10. South America Acute Cholecystitis Treatment Market Outlook

11. Middle East and Africa Acute Cholecystitis Treatment Market Outlook

12. Market Dynamics

13. Market Trends & Developments

14. Competitive Landscape

15. Strategic Recommendations

Companies Mentioned

  • Boston Scientific Corporation
  • Fresenius Kabi AG
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd.
  • Glenmark Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Becton, Dickinson and Company
  • Simulab Corporation
  • AbbVie, Inc.
  • Fortimedix Surgical BV

For more information about this report visit https://www.researchandmarkets.com/r/vchlca

Media Contact:

Research and MarketsLaura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/global-acute-cholecystitis-market-report-2022-health-insurance--government-initiatives-boosting-sector-growth-301674612.html

SOURCE Research and Markets

Older

FEDERAL HOME LOAN BANK OF BOSTON – 10-Q – MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Newer

Open Meeting of the Federal Advisory Committee on Insurance

Advisor News

  • I started using AI, but what now?
  • How to support an entrepreneur client with multiple businesses
  • Could a narrower focus help grow your practice?
  • U.S. debt hits $40 trillion: how to support concerned clients
  • Flourish brings private-bank-like cash solution to MassMutual’s network
More Advisor News

Annuity News

  • MassMutual Expands Lending Options With New Secured Credit Line
  • Corebridge Financial Introduces Progressive Trigger, a First-of-Its-Kind Index Annuity Strategy Designed to Turn Missed Years into Future Opportunity
  • Insurer proposes $1.1M deal to resolve CA teachers’ annuity fee lawsuit
  • IMOs get frustrated with slow carrier adoption of faster technology
  • New class-action lawsuit targets Delaware Life over annuity disclosures
More Annuity News

Health/Employee Benefits News

  • Health insurance hits municipal budgets, taxpayers hard
  • Minnesota seniors face tough choices for health plans
  • Recent Findings from New York University (NYU) Langone Health Provide New Insights into Managed Care (State Medicaid Body Mass Index Requirements for Solid Organ Transplant Coverage: A 50-State Policy Review): Managed Care
  • After booting 760K off ACA health plans, the Trump administration adds some people back
  • New Findings from University of Hawaii at Manoa in the Area of Science Reported (Expanded Medi-Cal Coverage and Persisting Access Barriers for Latino Immigrants in California): Science
More Health/Employee Benefits News

Life Insurance News

  • Virginia orders Atlantic Coast Life to halt new business Nov. 1
  • AM Best Affirms Credit Ratings of China Taiping Insurance (Singapore) Pte. Ltd.
  • AM Best Upgrades Credit Ratings of Fidelity Life Association, A Legal Reserve Life Insurance Company; Affirms Credit Ratings of Industrial Alliance Insurance and Financial Services Inc. and Its Life/Health Subsidiaries
  • 777 Partners founder pleads guilty to $500 million fraud scheme
  • AM Best Affirms Credit Ratings of Luen Fung Hang Insurance Company Limited
Sponsor
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
  • Lauren Sinnott Named to Ragan’s Top Women in Marketing Awards, Class of 2026 
  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.